Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients

The COVID-19 pandemic continues to be a worldwide health issue. Among hemodialysis (HD) patients, two-dose immunization schemes with mRNA vaccines have contributed to preventing severe COVID-19 cases; however, some have not produced a sufficient humoral response, and most have developed a rapid decl...

Descripción completa

Detalles Bibliográficos
Autores principales: Broseta, José Jesús, Rodríguez-Espinosa, Diana, Cuadrado, Elena, Rodríguez, Néstor, Bedini, José Luis, Maduell, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030003/
https://www.ncbi.nlm.nih.gov/pubmed/35455271
http://dx.doi.org/10.3390/vaccines10040522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030003/
https://www.ncbi.nlm.nih.gov/pubmed/35455271
http://dx.doi.org/10.3390/vaccines10040522

Ejemplares similares